153 related articles for article (PubMed ID: 23413156)
1. Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.
Takazaki KA; D'Abreu A; Nucci A; Lopes-Cendes I; França MC
Cerebellum; 2013 Aug; 12(4):513-9. PubMed ID: 23413156
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlates of autonomic dysfunction in patients with Machado-Joseph disease.
França MC; D'Abreu A; Nucci A; Lopes-Cendes I
Acta Neurol Scand; 2010 Jun; 121(6):422-5. PubMed ID: 20070275
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
4. Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Martinez AR; Nunes MB; Faber I; D'Abreu A; Lopes-Cendes Í; França MC
Cerebellum; 2017 Feb; 16(1):118-121. PubMed ID: 27021342
[TBL] [Abstract][Full Text] [Related]
5. Muscle excitability abnormalities in Machado-Joseph disease.
França MC; D'Abreu A; Nucci A; Lopes-Cendes I
Arch Neurol; 2008 Apr; 65(4):525-9. PubMed ID: 18413477
[TBL] [Abstract][Full Text] [Related]
6. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence.
Donis KC; Saute JA; Krum-Santos AC; Furtado GV; Mattos EP; Saraiva-Pereira ML; Torman VL; Jardim LB
Neurogenetics; 2016 Apr; 17(2):107-13. PubMed ID: 26780339
[TBL] [Abstract][Full Text] [Related]
7. Related factors of ICARS and SARA scores on spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Liao X; Wang J; Jiang H; Tang B; Shen L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):498-503. PubMed ID: 21743140
[TBL] [Abstract][Full Text] [Related]
8. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
9. Body mass index is inversely correlated with the expanded CAG repeat length in SCA3/MJD patients.
Saute JA; Silva AC; Souza GN; Russo AD; Donis KC; Vedolin L; Saraiva-Pereira ML; Portela LV; Jardim LB
Cerebellum; 2012 Sep; 11(3):771-4. PubMed ID: 22090366
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease.
Zhou J; Lei L; Shi Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141
[TBL] [Abstract][Full Text] [Related]
11. Spectral analysis of heart rate variability in patients with Machado-Joseph disease.
Asahina M; Katagiri A; Yamanaka Y; Akaogi Y; Fukushima T; Kanai K; Kuwabara S
Auton Neurosci; 2010 Apr; 154(1-2):99-101. PubMed ID: 20060786
[TBL] [Abstract][Full Text] [Related]
12. The correlation between magnetic resonance imaging features of the brainstem and cerebellum and clinical features of spinocerebellar ataxia 3/Machado-Joseph disease.
Liang X; Jiang H; Chen C; Zhou G; Wang J; Zhang S; Lei L; Wang X; Tang B
Neurol India; 2009; 57(5):578-83. PubMed ID: 19934555
[TBL] [Abstract][Full Text] [Related]
13. Age related axonal neuropathy in spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD).
Klockgether T; Schöls L; Abele M; Bürk K; Topka H; Andres F; Amoiridis G; Lüdtke R; Riess O; Laccone F; Dichgans J
J Neurol Neurosurg Psychiatry; 1999 Feb; 66(2):222-4. PubMed ID: 10071104
[TBL] [Abstract][Full Text] [Related]
14. Planning Future Clinical Trials for Machado-Joseph Disease.
Saute JAM; Jardim LB
Adv Exp Med Biol; 2018; 1049():321-348. PubMed ID: 29427112
[TBL] [Abstract][Full Text] [Related]
15. Cognitive deficits in Machado-Joseph disease correlate with hypoperfusion of visual system areas.
Braga-Neto P; Dutra LA; Pedroso JL; Felício AC; Alessi H; Santos-Galduroz RF; Bertolucci PH; Castiglioni ML; Bressan RA; de Garrido GE; Barsottini OG; Jackowski A
Cerebellum; 2012 Dec; 11(4):1037-44. PubMed ID: 22307858
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous sympathetic dysfunction in patients with Machado-Joseph disease.
Yamanaka Y; Asahina M; Akaogi Y; Fujinuma Y; Katagiri A; Kanai K; Kuwabara S
Cerebellum; 2012 Dec; 11(4):1057-60. PubMed ID: 22528966
[TBL] [Abstract][Full Text] [Related]
17. Neuromelanin imaging analyses of the substantia nigra in patients with Machado-Joseph disease.
Nakata Y; Sakamoto A; Kawata A
Neuroradiology; 2020 Nov; 62(11):1433-1439. PubMed ID: 32556403
[TBL] [Abstract][Full Text] [Related]
18. Sleep disorders in machado-joseph disease: frequency, discriminative thresholds, predictive values, and correlation with ataxia-related motor and non-motor features.
Pedroso JL; Braga-Neto P; Felício AC; Dutra LA; Santos WA; do Prado GF; Barsottini OG
Cerebellum; 2011 Jun; 10(2):291-5. PubMed ID: 21287304
[TBL] [Abstract][Full Text] [Related]
19. Dysautonomia in RFC1-related disorder: Clinical and neurophysiological evaluation.
Schmitt GDS; Lima FD; Matos PCAAP; Martinez ARM; González-Salazar C; Nucci A; Marques W; Barsottini OGP; Pedroso JL; França MC
Clin Neurophysiol; 2022 Oct; 142():68-74. PubMed ID: 35970061
[TBL] [Abstract][Full Text] [Related]
20. Caring for Machado-Joseph disease: current understanding and how to help patients.
D'Abreu A; França MC; Paulson HL; Lopes-Cendes I
Parkinsonism Relat Disord; 2010 Jan; 16(1):2-7. PubMed ID: 19811945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
